Trianon Ballroom

Tuesday, November 15, 2016

PROGRAM C : Management of pulmonary embolism : Do we know enough.

SESSION 17:     THE BASICS OF PE DIAGNOSIS AND TREATMENT
7:00   –   7:10 Introduction To The Symposium Frank J. Veith, MD
7:10   –   7:15 Welcome And IntroductionMichael R. Jaff, DO
7:15   –   7:25 The Basics Of Pulmonary Embolism:  What Is The Role Of The History, Exam, Biomarkers Raghu Kolluri, MD
7:25   –   7:35 What Does The CT For PE Actually Tell Us Brian B. Ghoshhajra, MD, MBA
7:35   –   7:50 What Is State-Of-The-Art Medical Therapy For PE Geno J. Merli, MD, MACP
7:50   –   8:00 Just Tell Me What I Need To Know:  When Do I Look For Cancer And Perform Hypercoagulable Tests In PE Rachel Rosovsky, MD, MPH
8:00   –   8:10 Setting The Stage:  The Emergency Physician Algorithm For Acute PE Management D. Mark Courtney, MD  
8:10   –   8:25 Intravenous Thrombolytic Therapy For PE:  Does It Actually Work, And Safely Mitchell D. Weinberg, MD
8:25   –   8:35 Catheter-Directed Thrombolysis For PE:  What Are The Outcomes Divya Sridhar, MD
8:35   –   8:45 Percutaneous Pharmacomechanical Intervention For PE:  Is There A Rationale Gary M. Ansel, MD
8:45   –   9:15 Case Presentations/Discussion/Questions and Answers

SESSION 18:     ADVANCED INTERVENTIONAL TREATMENT FOR PE
9:45   –   9:55 Technical Tips For Pharmacomechanical Intervention For PE:  How Do I Do It Tod C. Engelhardt, MD
9:55   –  10:05 Pulmonary Embolism Intervention With Angiojet Jeffrey Y. Wang, MD
10:05  –  10:15 Vortex Strategy For Massive PE Christopher J. Kwolek, MD
10:15  –  10:30 ECMO And Surgical Thromboembolectomy For Massive PE: When, How And Why Georges M. Haidar, MD Mark G. Davies, MD
10:30  –  10:45 What Is The Modern Algorithm For Management Of Massive And Submassive PE Ido Weinberg, MD, MSc
10:45  –  11:00 Vena Cava Filters In PE Treatment:  Do We Need To Do This, And If So, When Amy R. Deipolyi, MD, PhD
11:00  –  11:15 Balloon Angioplasty For Chronic Thromboembolic Pulmonary Hypertension:  Is This Crazy Ehtisham Mahmud, MD
11:15  –  11:30 The Team Approach To PE Management:  The Emergence Of National PERT Centers Kenneth Rosenfield, MD
11:30  –  11:45 Challenging Cases And “PERT” Decisions

PROGRAM C : New developments in the management of acute and chronic large vein occlusion.

SESSION 19:     THE RECENT EXPLOSION IN VENOUS INTERVENTIONAL TECHNOLOGIES: NEW OPPORTUNITIES FOR THE PATIENT
SESSION 20:     ACUTE DVT: ENDOVASCULAR INTERVENTIONS AND PHARMACOLOGIC REGIMENS
SESSION 21:     NEW DEVICES AND IMAGING TECHNOLOGIES TO ACHIEVE SUPERIOR OUTCOMES IN TREATING LARGE VEIN OBSTRUCTION
SESSION 22:     MY WORST VENOUS DISASTER OF 2016: RAPID-FIRE PRESENTATION OF RESCUES AND LESSONS LEARNED

Wednesday, November 16, 2016

PROGRAM F : New developments in arch and thoracic aortic disease, dissections, parellel grafts, F/B endografts, TAAAs, Multilayer flow modulating grafts, abdominal aneurysms, EVAR and recorded live complex cases.

SESSION 39:     MORE TOPICS RELATED TO TEVAR, THE THORACIC AORTA AND TREATMENT OF AORTIC DISSECTIONS
SESSION 40:     TREATMENT OF LESIONS OF THE ASCENDING AORTA, THE AORTIC ARCH; PARALLEL GRAFTS AND OTHER METHODS AND DEVICES FOR TREATMENT
SESSION 41:     MORE ABOUT JUXTA- AND PARARENAL AAAs; TAAAs; F/BEVAR; PARALLEL GRAFTS
SESSION 42:     UPDATE ON THE MULTILAYER FLOW MODULATING (MLFM) STENTS AND OTHER UNCOVERED STENTS FOR THE TREATMENT OF ANEURYSMS AND DISSECTIONS
SESSION 43:     MORE INTERESTING TOPICS RELATED TO THE ABDOMINAL AORTA, AAAs AND EVAR
SESSION 44:     MORE NEW DEVELOPMENTS RELATING TO AAAs AND EVAR
SESSION 45:     INTERESTING RECORDED LIVE ENDOVASCULAR CASES AND THOSE EMPLOYING NEW AND INNOVATIVE TECHNIQUES
SESSION 46:     RECORDED LIVE CASES FROM LEIPZIG AND LINC: REMAINING CHALLENGES AND LATEST INNOVATIONS IN ENDOVASCULAR INTERVENTIONS

Thursday, November 17, 2016

PROGRAM I : Superficial venous disease and varicose veins.

SESSION 63:     VENOUS CLINICAL EXAMINATION AND HEMODYNAMICS
7:31 – 7:36 Establishing  e Treatment Plan With CEAP & VCSS Jose I. Almeida, MD, RPVI, RVT"
7:37 – 7:42 Outcome Assessment Of CVD Lowell S. Kabnick, MD, RPhS"
7:43 – 7:48 Identifying Re ux Pathways With Duplex Ultrasound Mapping Neil M. Khilnani, MD
7:49 – 7:54 Symptoms Of Chronic Venous Disease: De nition And Signi cance Raghu Kolluri, MD
7:55 – 8:00 Venous Flow And Pressure: Modern Concepts Seshadri Raju, MD"
8:01 – 8:06 Physiology Of Venous Return Brajesh K. Lal, MD"
8:07 – 8:12 What Is Chronic Venous Dysfunction Joseph D. Ra etto, MD  "
8:13 – 8:18 Saphenous Sparing Venous Surgery: ASVAL Technique  Sylvain Chastanet, MD
8:19 – 8:24 Hemodynamics-Based Venous Surgery: Technique Todd Berland, MD  "

SESSION 64:     VENOUS IMAGING TECHNIQUES
8:31 – 8:36 The Optimal Venogram: My Technique Akhilesh K. Sista, MD"
8:37 – 8:42 How To Recognize Variants On  e Venous Duplex Exam Neil M. Khilnani, MD"
8:43 – 8:48 How And What Should  e Venous Duplex Examination Include Mark H. Meissner, MD"
8:49 – 8:54 What Is So Magical About Re ux Time: Can You Predict Venous Disease Severity William A. Marston, MD"
8:55 – 9:00 Vein Diameter Is Not  e Key For Stratifying Interventional Strategies For Super cial Venous Disease Alun H. Davies, MA, DM, DSc"
9:01 – 9:06 Re ux Elimination Test: Imaging For Saphenous Sparing Technique Sylvain Chastanet, MD"
9:07 – 9:12 The Argument Against Routine Duplex Ultrasound A er Truncal Ablation: An Evidence-Based Cost- Bene t Analysis Thomas F. O’Donnell, Jr., MD"

SESSION 65:     SUPERFICIAL VEIN TREATMENT STRATEGIES AND TECHNIQUES
9:19 – 9:24 Matching  e Endovenous Modality To  e Individual: A Real-World Evaluation Manj S. Gohel, MD"
9:25 – 9:30 Concomitant Treatment Of Truncal Re ux And Varicosed Tributaries Is  e Gold Standard Alun H. Davies, MA, DM, DSc
9:31 – 9:36 Lessons Learned: RF Ablation Alan M. Dietzek, MD, RPVI"
9:37 – 9:42 Lessons Learned: Laser Ablation Jean Luc Gerard, MD"
9:43 – 9:48 Step By Step: Phlebectomy Paul Pittaluga, MD"
9:49 – 9:54 Super cial Re ux With Obstructed Deep Veins: When And When Not To Treat Jose I. Almeida, MD, RPVI, RVT"
9:55 – 10:00 Incidence, Causes, And Treatment Of Recurrent Varicose Veins Following Endovenous  ermal Ablation Edward G. Mackay, MD"
10:07 – 10:12 Challenges Of Implementing Proprietary Foam Into Practice: It’s Kind Of A Di erent Practice Model Kathleen D. Gibson, MD`
10:13 – 10:18 Step By Step: Cyanoacrylate Embolic Adhesive Mr. Ian J. Franklin, MS"
10:19 – 10:24 Cyanoacrylate Embolic Adhesive vs. RFA: 2-Year Follow-Up PIVOTAL Trial Raghu Kolluri, MD"
10:25 – 10:30 Perforating Vein Closure With Turkish Cyanoacrylate Adhesive: Interim Results Of 40 Patients Kursat A. Bozkurt, MD"
10:31 – 10:36 Lessons Learned: MOCA Ablation Alun H. Davies, MA, DM, DSc"
10:37 – 10:42 Mechanochemical Ablation:  e 3-Year Outcome Of A Prospective Trial On 100 Patients With GSV Incompetence Michel M.P. Reijnen, MD, PhD"
10:43 – 10:48 Re ux Extending To  e Ankle: When And How To Treat Steve Elias, MD"
10:49 – 10:54 Concomitant Truncal Venous Incompetence And Lymphedema: To Ablate Or Not To Ablate Paul Pittaluga, MD"

SESSION 66:     VENOUS SOCIETAL AND GOVERNANCE
11:01 – 11:06 IAC Vein Center Accreditation: Is It Important Alan M. Dietzek, MD, RPVI"
11:07 – 11:12 CMS Policy, Payments And Pitfalls Harold J. Welch, MD"
11:13 – 11:18 The Process For New Devices: CPT Code, RUC, Insurance Sean P. Roddy, MD"
11:19 – 11:24 Outpatient Interventions: Are Controls Needed Paul J. Gagne, MD"
11:25 – 11:30 VQI Varicose Vein Registry: First Six Months Results Thomas W. Wake eld, MD"
11:31 – 11:36 A National Coverage Determination Policy Lowell S. Kabnick, MD, RPhS"
11:37 – 11:42 How To Have A Paper Accepted To JVS Venous And Lymphatic And JVS Case Report Peter F. Lawrence, MD"
11:43 – 11:48 How Do Venous Leaders Deal With Over-Utilization And Inappropriate Use Steve Elias, MD"
11:49 – 11:54 We Need A Joint Venous Council Jose I. Almeida, MD, RPVI, RVT"

SESSION 67:     EXAMINING THE EVIDENCE
1:00 – 1:05  Review Of RCTs Comparing Foam Sclerotherapy And Endothermal Ablation Andrew W. Bradbury, MD"
1:06 – 1:11  Cyanoacrylate Adhesive: More  an One Product Available: Is  ere A Di erence Mr. Ian J. Franklin, MS"
1:12 – 1:17 ASVAL For  e Small Saphenous Vein Sylvain Chastanet, MD"
1:18 – 1:23 C6 With Arterial Claudication: Which Comes First William A. Marston, MD "
1:24 – 1:29 Thermal Ablation On Anticoagulated Patients: Is It Safe And E ective Glenn Jacobowitz, MD"
1:30 – 1:35 Is there A Need To Correct A Re uxing Accessory  igh Vein Elna M. Masuda, MD"
1:36 – 1:41 Is C2 Disease Progressive Mark H. Meissner, MD"
1:42 – 1:47 Why Graduated Compression Is An Insurance Requirement Fedor Lurie, MD, PhD"

SESSION 68:     MORE USEFUL SUPERFICIAL VEIN INFORMATION
1:54 – 1:59 What Is  e Duplex Criteria For Pediatric Re ux Testing Dawn M. Coleman, MD"
2:00 – 2:05 Sclerotherapy Pearls Edward G. Mackay, MD"
2:06 – 2:11 Should You Use Foam For Telangiectasia Or Reticular Veins: Where Is  e Evidence Mr. Ian J. Franklin, MS"
2:12 – 2:17 How To Treat Labial Varices: Sclerotherapy vs. Phlebectomy Ellen D. Dillavou, MD"
2:18 – 2:23 Physician Compounded Foam vs. Proprietary Compounded Foam Lowell S. Kabnick, MD, RPhS"
2:24 – 2:29 Laser Or Ohmic Devices For Telangiectasia: When And Why Mr. Ian J. Franklin, MS"
2:30 – 2:35 Management Of Calf Vein  rombosis A er Venous Procedures Elna M. Masuda, MD"
2:36 – 2:41 SVT In  e Pregnant Patient Ellen D. Dillavou, MD"

SESSION 69:     SUPERFICIAL VENOUS ABLATION, COMPRESSION, AND RESEARCH
2:48 – 2:53 How To Properly Design And Interpret Clinical Trials Thomas W. Wake eld, MD"
2:54 – 2:59 The Maradona Trial: RCT Comparing MOCA With RFA Michel M.P. Reijnen, MD, PhD"
3:00 – 3:05 Creating WAVES: First US Post Market Results Using VenasealTM Closure System Without Compression Kathleen D. Gibson, MD
3:06 – 3:11 Are Stockings Still Indicated A er DVT – What Is  e Evidence Fedor Lurie, MD, PhD"
3:12 – 3:17 Does It Matter What Device You Use Regarding Vein Wall  ickness Mark S. Whiteley, MS"
3:18 – 3:23 Endovenous  ermal Ablation RCTs: Do We Know Enough Bo G. Eklof, MD, PhD"
3:24 – 3:29 SECURE Trial: Update On Perforator Ablation Mark A. Adelman, MD"
3:30 – 3:35 When Should We Use Prophylactic Anticoagulation In Saphenous Ablation Joseph A. Caprini, MD"
3:36 – 3:41 How Do Compression Garments Actually Work John Blebea, MD, MBA"
3:42 – 3:47 Which Patients Bene t From A Lymphedema Pump Thomas S. Maldonado, MD"
3:48 – 3:53 When To Use Inelastic Compression Joseph A. Caprini, MD"

SESSION 70:     VENOUS PRACTICE MANAGEMENT . . . AND A LITTLE FUN
4:01 – 4:06 Non-Thermal Devices Are Available For Truncal Ablation: How To Implement In Practice Without Dedicated CPT Codes Steve Elias, MD"
4:07 – 4:12 DEBATE: C2 Disease Should Not Be A Covered Insurance Bene t Jose I. Almeida, MD, RPVI, RVT"
4:13 – 4:18 DEBATE: C2 Disease Should Be A Covered Insurance Bene t Alan M. Dietzek, MD, RPVI"
4:19 – 4:24 The Future Of Venous Reimbursement In A Non-Fee For Service Environment Thomas F. O’Donnell, Jr., MD"
4:25 – 4:30 The Efficient Venous Practice: Evaluate With Lean Six Sigma Christopher M. Banoub, MPA"

Friday, November 18, 2016

PROGRAM L : Deep venous disease.

SESSION 87:     VENOUS CROSS-SECTIONAL IMAGING TECHNIQUES, PELVIC VENOUS DISORDERS
SESSION 88:     FEMORO-ILIOCAVAL INTERVENTIONAL STRATEGIES TO REDUCE VENOUS HYPERTENSION, HOT IDEAS FOR RECANALIZING CHRONIC TOTAL OCCLUSIONS
SESSION 89:     STRATEGIES FOR CORRECTING SEVERE DEEP VENOUS REFLUX AND/OR OBSTRUCTION; WOUNDS AND NEW HORIZONS FOR VENOUS DISEASE MANAGEMENT
SESSION 90:     STRATEGIES FOR THROMBOEMBOLIC EVENTS IN THE VENOUS SYSTEM INCLUDING THE AXILLO SUBCLAVIAN SYSTEM
SESSION 91:     ENDOVASCULAR AND OPEN SOLUTIONS FOR INFERIOR VENA CAVA TUMORS AND OCCLUSIONS, VENA CAVA FILTRATION STRATEGIES, PITFALLS, AND COMPLICATIONS AND MORE ABOUT ILIAC VEIN STENTING

0Rejoindre la discussion
Trianon Ballroom - Discussion